Spark Therapeutics to Participate in Multiple Conferences in June
Jun 01, 2017 11:38 am UTC| Business
PHILADELPHIA, June 01, 2017 -- Spark Therapeutics (NASDAQ:ONCE), a fully integrated gene therapy company dedicated to challenging the inevitability of genetic disease, today announced that company management will...
Spark Therapeutics to Participate in Multiple Conferences in June
Jun 01, 2017 11:38 am UTC| Business
PHILADELPHIA, June 01, 2017 -- Spark Therapeutics (NASDAQ:ONCE), a fully integrated gene therapy company dedicated to challenging the inevitability of genetic disease, today announced that company management will...
Spark Therapeutics to Participate in Multiple Conferences in June
Jun 01, 2017 11:38 am UTC| Business
PHILADELPHIA, June 01, 2017 -- Spark Therapeutics (NASDAQ:ONCE), a fully integrated gene therapy company dedicated to challenging the inevitability of genetic disease, today announced that company management will...
Spark Therapeutics to Participate in Multiple Conferences in June
Jun 01, 2017 11:38 am UTC| Business
PHILADELPHIA, June 01, 2017 -- Spark Therapeutics (NASDAQ:ONCE), a fully integrated gene therapy company dedicated to challenging the inevitability of genetic disease, today announced that company management will...
Spark Therapeutics to Participate in Multiple Conferences in June
Jun 01, 2017 11:38 am UTC| Business
PHILADELPHIA, June 01, 2017 -- Spark Therapeutics (NASDAQ:ONCE), a fully integrated gene therapy company dedicated to challenging the inevitability of genetic disease, today announced that company management will...
Spark Therapeutics to Participate in Multiple Conferences in June
Jun 01, 2017 11:38 am UTC| Business
PHILADELPHIA, June 01, 2017 -- Spark Therapeutics (NASDAQ:ONCE), a fully integrated gene therapy company dedicated to challenging the inevitability of genetic disease, today announced that company management will...
Spark Therapeutics to Participate in Multiple Conferences in June
Jun 01, 2017 11:38 am UTC| Business
PHILADELPHIA, June 01, 2017 -- Spark Therapeutics (NASDAQ:ONCE), a fully integrated gene therapy company dedicated to challenging the inevitability of genetic disease, today announced that company management will...